SynthesisFrontiers in medicine2026
Preoperative neutrophil-to-lymphocyte ratio and systemic immune-inflammation index as prognostic biomarkers for postoperative pneumonia and pulmonary complications after thoracic surgery: a systematic review and meta-analysis.
Synthesis in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Postoperative pneumonia and pulmonary complications are major adverse events following thoracic surgery. The neutrophil-to-lymphocyte ratio (NLR) and systemic immune-inflammation index (SII), two circulating immune-inflammatory biomarkers derived from routine complete blood counts, have been individually associated with postoperative outcomes, but no quantitative synthesis has specifically evaluated their prognostic value for pulmonary outcomes after lung resection or esophagectomy. Methods: A systematic search of PubMed, Embase, Web of Science, Scopus, CENTRAL, CNKI, and Wanfang Data was conducted from inception to 11 April 2026. Observational studies reporting associations between preoperative NLR and/or SII and postoperative pneumonia or pulmonary complications in adults undergoing lung resection or esophagectomy were eligible. A hierarchical framework prioritized continuous associations as the primary synthesis, with categorical high-versus-low comparisons as secondary. Random-effects models with restricted maximum likelihood estimation and the Hartung-Knapp adjustment were used, and certainty of evidence was assessed using GRADE. Results: Eight retrospective cohort studies comprising 3,936 patients were included. Higher preoperative NLR and SII showed directionally consistent associations with increased postoperative pulmonary risk across all analyses. For NLR, continuous analyses suggested an approximately twofold increase in the odds of postoperative pneumonia per one-unit increment, and categorical analyses an approximately fourfold increase above study-specific thresholds. For SII, the continuous association was more modest, while categorical analyses indicated more than twice the odds above study-specific cut-offs. However, Hartung-Knapp confidence intervals crossed unity in three of the four pooled analyses, reflecting the very small number of contributing studies (k = 2-3 per analysis), and the overall certainty of evidence was low to very low. Conclusion: Higher preoperative NLR and SII may be associated with an increased risk of postoperative pneumonia and related pulmonary complications after thoracic surgery, but the evidence base remains small, exclusively retrospective, and geographically concentrated. These low-cost immune-inflammatory indices should be regarded as promising, hypothesis-generating prognostic markers that require confirmation in larger, prospective, and methodologically standardized studies before they can be considered for routine perioperative risk stratification. Systematic review registration: https://www.crd.york.ac.uk/PROSPERO/view/CRD420261329394, identifier PROSPERO (CRD420261329394).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.